Early response gene signalling in bryostatin-stimulated primary B chronic lymphocytic leukaemia cells in vitro.
AffiliationDivision of Life Sciences, King's College London, U.K.
MetadataShow full item record
AbstractThe protein kinase C activator bryostatin induces differentiation and antagonizes the effects of tumour-promoting phorbol esters in a number of different cell types. We show here that bryostatin preferentially inhibits phorbol 12-myristate 13-acetate (PMA)-induced proliferation compared with differentiation in a number of different B chronic lymphocytic leukaemia (BCLL) cell populations examined. By using a panel of 11 early-response gene probes in Northern hybridization analysis, we found that the profile of genes induced in response to bryostatin and PMA was qualitatively similar and displayed comparable sensitivities to inhibition with the serine-threonine kinase inhibitor 1-(5-isoquinolinylsulphonyl)-2-methylpiperazine hydrochloride (H7), consistent with common signalling through protein kinase C. However, the nuclear oncogene. c-myc, which was induced strongly in response to PMA treatment, was only marginally up-regulated by bryostatin. In addition, bryostatin selectively inhibited the magnitude of PMA-responsive induction of c-myc, to a degree commensurate with its antagonistic effects seen at the biological level. Finally, an anti-sense oligonucleotide blockade of c-myc inhibited PMA-induced proliferation but not the differentiation of BCLL cells, implicating this nuclear oncogene as an important determinant distinguishing PMA from bryostatin-coupled biological responses and also as a candidate third-messenger effector target for the anti-tumour effects of bryostatin.
CitationEarly response gene signalling in bryostatin-stimulated primary B chronic lymphocytic leukaemia cells in vitro. 1996, 319 ( Pt 1):59-65 Biochem. J.
JournalThe Biochemical Journal
- Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation.
- Authors: Drexler HG, Gignac SM, Pettit GR, Hoffbrand AV
- Issue date: 1990 Jan
- Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
- Authors: Vrana JA, Saunders AM, Chellappan SP, Grant S
- Issue date: 1998 May
- Potentiation of ara-C-induced apoptosis by the protein kinase C activator bryostatin 1 in human leukemia cells (HL-60) involves a process dependent upon c-Myc.
- Authors: Chelliah J, Freemerman AJ, Wu-Pong S, Jarvis WD, Grant S
- Issue date: 1997 Sep 1
- Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells.
- Authors: Thomas A, Pepper C, Hoy T, Bentley P
- Issue date: 2004 May
- Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
- Authors: Szallasi Z, Denning MF, Smith CB, Dlugosz AA, Yuspa SH, Pettit GR, Blumberg PM
- Issue date: 1994 Nov